Purdue Pharma ran an unprecedented, aggressive and multi-faceted marketing campaign from 1996 to the early 2000s that helped kickstart the nation’s current opioid crisis.
Senate committee scorches Purdue Pharma and other firms ‘These financial relationships were insidious, lacked transparency’ The five biggest companies making prescription opioids have been accused by a US Senate committee of spending...Show More Summary
(Reuters) - Five opioid manufacturers including OxyContin maker Purdue Pharma LP have paid more than $10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkillers, a U.S. Senate report said on Monday.
OxyContin will no longer be marketed to doctors after states leveled drugmaker Purdue Pharma with lawsuits.
The decision by Purdue Pharma comes as theindustry battles an avalanche of lawsuits across the nation related to the opioid crisis.
The decision by Purdue Pharma comes as the company battles an avalanche of lawsuits across the nation related to the opioid crisis.
Purdue Pharma also said it will cut its sales force by about half.
Purdue Pharma announced that it will be cutting OxyContin sales staff in an effort to stop promoting the drug to prescribers and pharmacies in the U.S. The company has been accused of using controversial marketing practices that falsely...Show More Summary
(Reuters) - OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers.
Marketing efforts will be directed at a treatment for opioid-induced constipation, the company said.
This is a major about-face for Purdue Pharmaceuticals. / > Related Stories Trump Wants to Get Mean With "Drug Pushers" --But What About Big Pharma? Opioid Crisis Hits Hardest in Areas Hit by Climate Stress, Declining Farm Incomes Citing Infamous Big Tobacco Hearing, Sanders Wants Drug CEOs to Testify on Opioid Crisis
The manufacturer of the powerful painkiller OxyContin announced this week that it will stop promoting its opioid drugs to doctors after years of criticism and mounting lawsuits, some based in part on a Times investigation. Connecticut-based Purdue Pharma informed its employees that it was cutting...
(Reuters) - Alabama on Tuesday became the latest state to file a lawsuit accusing OxyContin maker Purdue Pharma LP of fueling the opioid epidemic by deceptively marketing prescription painkillers to generate billions of dollars in sales.
New Yorker magazine had a very good piece on the history of Purdue Pharma and its successful marketing of OxyContin. It is worth noting that if the company had not had a government granted patent monopoly on OxyContin, it would have had little incentive to mislead doctors and the general public about the extent to which the drug was addictive. Show More Summary
Opioid Czar & Czarina Mike Magee When the AMA helped empower Purdue Pharma funded Pain Management by granting specialty status in its’ Federation in the 1980s– and with that legitimacy of pain as the “5th vital sign”; and when everyday...Show More Summary
Company complicit in hundreds of thousands of deaths claims “This is our fight, too.”
(Reuters) - Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.
(Reuters) - New Jersey on Tuesday sued Purdue Pharma LP, maker of the chronic pain medication OxyContin, accusing the company of engaging in deceptive marketing practices that contributed to what it called the state's opioid crisis.
We take a hard look at the role of Purdue Pharma, the makers of OxyContin, in the opioid crisis. And a piece of theatre by teen girls captures the trauma of sexual assault.
As reported by Bloomberg:Federal prosecutors in Connecticut began a criminal investigation into Purdue Pharma Inc.’s marketing of the controversial opioid painkiller OxyContin.U.S. Attorney Deirdre Daly is gathering documents about Purdue’s claim that OxyContin provides 12 hours of pain relief. Show More Summary